[MYGN] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
06-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -105.34%
YoY- -100.86%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 167,300 145,200 186,300 202,300 190,200 177,500 183,500 -1.52%
PBT 39,800 -43,700 -22,300 800 86,600 4,000 43,500 -1.46%
Tax 15,200 -28,500 -1,700 1,600 5,600 5,200 16,900 -1.74%
NP 24,600 -15,200 -20,600 -700 81,100 -1,200 26,600 -1.29%
Tax Rate -38.19% - - -200.00% -6.47% -130.00% -38.85% -
Total Cost 142,700 160,400 206,900 203,000 109,100 178,700 156,900 -1.56%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin 14.70 -10.47 -11.06 -0.35 42.64 -0.68 14.50 0.22%
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS 0.31 -0.20 -0.28 -0.01 1.18 -0.02 0.39 -3.75%
EPS Diluted 0.30 -0.20 -0.28 -0.01 1.15 -0.02 0.37 -3.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.